PacBio appoints NeoGenomics CEO Chris Smith to board; David Meline resigns

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Chris Smith, CEO of NeoGenomics (NEO), appointed to PacBio Board effective Jan 30, 2025.
David Meline resigned from Board effective Jan 30, 2025; no disagreement cited.
Smith brings diagnostics and genomics expertise as PacBio expands into clinical genomics.
Smith previously led Ortho Clinical Diagnostics (sold to Quidel) and Cochlear Limited.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher M. Smith

Class III Director

PACB · PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Effective: 2025-01-30
Filed: January 30, 2025, 6:59 PM ET

appointed Christopher M. Smith to serve as a Class III director effective January 30, 2025

Departed

David Meline

Director

PACB · PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Effective: 2025-01-30
Filed: January 30, 2025, 6:59 PM ET

David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher M. Smith was appointed as Class III Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Action: appointed
Role: Class III Director

Exact text from the filing

appointed Christopher M. Smith to serve as a Class III director effective January 30, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Meline resigned as Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Action: resigned
Role: Director

Exact text from the filing

David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025

View on SEC.gov

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. filing history →

Source: SEC EDGAR

accession 0001299130-25-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.